Pilot Award Recipient: Magali Moretto, PhD
In recent years, microsporidia species have rapidly emerged as human enteric pathogens in HIV infected individuals.
Pilot Awards Recipients Archive
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science since 2017.
Pilot Award Recipient: David Leitenberg, MD, PhD
Infection with Toxoplasma gondii can cause significant morbidity and mortality in patients with HIV/AIDS-associated immunosuppression.
Pilot Award Recipient: Priscilla Dass-Brailsford, EdD
The District of Columbia (DC) has one of the highest HIV prevalence rates (3%) in the U.S. and women accounted for 29% of all new HIV infections in 2009.
Pilot Award Recipient: Jennifer Huang Bouey, MBBS, PhD, MPH
Although conventional wisdom ties drug use and sexual risks to younger populations, the incidence of both HIV and drug abuse have reportedly shown the greatest increase among China's growing middle-...
Pilot Award Recipient: Manya Magnus, PhD, MPH
The prevalence of HIV among individuals in the United States 50 years and older has grown substantially with increased antiretroviral availability and improved care.
Pilot Award Recipient: Ricardo LaGrange PhD
The issue of non-adherence to antiretroviral (ARV) medication presents a considerable barrier to treatment for adolescents preparing to transition to adult care.
Pilot Award Recipient: Michelle L. Stock, PhD
Among 20-24 year olds, the rate of HIV/AIDS is 14 times higher for Blacks than it is for other racial groups.
Pilot Award Recipient: Brian M. Kirmse, MD
The drugs used to treat HIV infection (antiretrovirals, or ARV's) are known to be toxic to the mitochondria, the "batteries of the cells."
Pilot Award Recipient: Sergey Iordanskiy, PhD, MS
HIV is capable to infect non-dividing cells and translocate a DNA copy of its RNA genome through the nuclear envelope to the site of integration in the host cell chromatin.